Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Invesco DB Agriculture Fund
DBA
$1.23B
| $814K | ﹤0.01% |
40,398
-150,558
| -79% | -$3.01M |
|
2902
MasTec
MTZ
$21.8B
| $811K | ﹤0.01% |
9,508
-162,243
| -94% | -$13.3M |
|
2903
AdaptHealth
AHCO
$941M
| $810K | ﹤0.01% |
42,152
-149,123
| -78% | -$3.15M |
|
|
CALY
2904
CALL
Callaway Golf Company
CALY
$3.45B
| $810K | ﹤0.01% |
+41,000
| New | +$808K |
|
|
AVNS
2905
DELISTED
Avanos Medical
AVNS
| $808K | ﹤0.01% |
29,875
-5,172
| -15% | -$126K |
|
2906
CALL
Acadia Pharmaceuticals
ACAD
$4.92B
| $806K | ﹤0.01% |
+50,600
| New | +$791K |
|
2907
PUT
SoFi Technologies
SOFI
$23.9B
| $805K | ﹤0.01% |
+174,600
| New | +$866K |
|
2908
Icahn Enterprises
IEP
$4.98B
| $805K | ﹤0.01% |
15,884
-1,544
| -9% | -$80.5K |
|
2909
Northwest Natural Holdings
NWN
$2.06B
| $802K | ﹤0.01% |
16,861
+6,943
| +70% | +$326K |
|
2910
NewMarket
NEU
$8.19B
| $802K | ﹤0.01% |
2,578
+381
| +17% | +$117K |
|
2911
Quanex
NX
$970M
| $801K | ﹤0.01% |
33,810
+10,215
| +43% | +$230K |
|
2912
Primoris Services
PRIM
$4.61B
| $800K | ﹤0.01% |
36,483
+22,044
| +153% | +$446K |
|
2913
Innoviva
INVA
$1.52B
| $795K | ﹤0.01% |
60,011
-7,053
| -11% | -$92.7K |
|
2914
Horizon Bancorp
HBNC
$1.06B
| $795K | ﹤0.01% |
52,722
+10,543
| +25% | +$174K |
|
|
VGR
2915
DELISTED
Vector Group Ltd.
VGR
| $794K | ﹤0.01% |
66,909
+32,290
| +93% | +$341K |
|
2916
Fomento Económico Mexicano
FMX
$43B
| $793K | ﹤0.01% |
10,154
+3,643
| +56% | +$268K |
|
2917
Arvinas
ARVN
$550M
| $793K | ﹤0.01% |
23,183
-13,593
| -37% | -$572K |
|
2918
Ezcorp Inc
EZPW
$1.89B
| $792K | ﹤0.01% |
97,197
+16,285
| +20% | +$145K |
|
|
CSTR
2919
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $791K | ﹤0.01% |
44,816
+1,756
| +4% | +$31.2K |
|
|
TGI
2920
DELISTED
Triumph Group
TGI
| $791K | ﹤0.01% |
75,167
+12,725
| +20% | +$132K |
|
2921
Rush Enterprises Class B
RUSHB
$6.29B
| $790K | ﹤0.01% |
21,070
+1,986
| +10% | +$70.2K |
|
2922
Armstrong World Industries
AWI
$7.85B
| $790K | ﹤0.01% |
11,515
-42,699
| -79% | -$3.23M |
|
2923
Deluxe
DLX
$1.22B
| $788K | ﹤0.01% |
46,403
+31,149
| +204% | +$554K |
|
|
VISN
2924
Vistance Networks Inc
VISN
$2.8B
| $786K | ﹤0.01% |
106,942
-45,055
| -30% | -$435K |
|
2925
PUT
Delta Air Lines
DAL
$61.8B
| $785K | ﹤0.01% |
+23,900
| New | +$792K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.